Advertisement
Singapore markets closed
  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • Bitcoin USD

    60,752.75
    -2,029.39 (-3.23%)
     
  • CMC Crypto 200

    1,258.98
    -99.03 (-7.29%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • Dow

    39,512.84
    +125.08 (+0.32%)
     
  • Nasdaq

    16,340.87
    -5.40 (-0.03%)
     
  • Gold

    2,366.90
    +26.60 (+1.14%)
     
  • Crude Oil

    78.20
    -1.06 (-1.34%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

EW Traded at Its 52-Week High on September 28

EW Traded at Its 52-Week High on September 28

On September 27, Edwards Lifesciences (EW) ended trading at a closing price of $172.16. The stock traded at its record high of $172.54 on September 27. The stock continued its bull run after it increased ~7.7% on September 25. A Wells Fargo analyst suggested Edwards Lifesciences or Boston Scientific as the potential acquisitions for Johnson & Johnson (JNJ). The company registered strong second-quarter results on July 26. However, the stock registered a fall of ~5.8% in the after-hours trading. Since then, Edwards Lifesciences stock has risen ~22%. ...